subject: Juvederm Ultra From Canada [print this page] Another Hyaluronic acid filler gaining popularity is Juvderm manufactured by the same company that makes Botox cosmetic injectable. Juvderm is also FDA approved, non-animal dermal filler gel used to correct mid to deep dermis wrinkles. Juvderm works best on wrinkles in the lower 1/3 of the face like nasolabial folds (smile or laugh lines) and oral commissures (marionette lines).
After Juvederm is injected, it fills the desired area by attracting and binding the body's water to the treatment area.
Among of the differences in Juvderm and other Hyaluronic acid fillers is that it comes in two formulas: Juvderm Ultra and Juvderm Ultra Plus. Both are used to treat different wrinkle depths of area's needing to be filled. In addition, the base of the injectable is smooth gel vs. a granular gel used by some other fillers. Juvderm has been tested and shows no hypertrophic scaring in patients of color.
The injection process is similar to that of other Hyaluronic acid fillers including a thorough consultation prior to treatment. The injection area will be determined and cleansed removing all makeup and Juvderm will be injected with an ultra fine needle. Treatment will take approximately 15 minutes and immediately after the injection the medical provider may massage the area to even the distribution of the filler to the area.
Juvderm patients should avoid excess sun, strenuous activity and alcohol for a 24 hour period to minimize the risk of swelling and erythema.
Results for both Juvderm Ultra and Juvderm Ultra Plus are around 6 months but additional treatments could be needed after that to maintain long-lasting results.
There are some contraindications and considerations to Juvderm which include the following:
Juvderm patients with a history of anaphylaxis or multiple severe allergies.
Juvderm patients with an allergic history to gram-positive bacterial protein.
Juvderm patients that have recently undergone laser, chemical peel or other procedures requiring a dermal response.
Juvderm patients with a lower immune response may have an increased risk of infection.
Safety for pregnant women and people under the age of 18 has not been resolved.
